Abstract:Our previous analyses indicated that both estrogen receptor (ER) subtypes, ERalpha and ERbeta, contribute to estrogen neuroprotection [Zhao, L., Wu, T.-W., Brinton, R.D., 2004. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010, 22-34]. In the present study, we sought to determine the underlying mechanisms by which ERalpha and ERbeta promote neuronal function, with a focus on neuroprotection, and whether these mechanisms are consistent with a classical nuclear or membrane ER-mediated response. Results of these analyses demonstrated that both the ERalpha-selective agonist, PPT (100 pM), and the ERbeta-selective agonist, DPN (100 pM), were effective in dynamically but differentially regulating intracellular calcium (Ca(2+)) signaling in hippocampal neurons. Consistent with the direct measurement of neuroprotective outcomes [Zhao, L., Wu, T.-W., Brinton, R.D., 2004. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010, 22-34], PPT and DPN exerted comparable efficacy in attenuating excitotoxic glutamate (200 microM)-induced intracellular Ca(2+) rise. In contrast, DPN was more efficacious than PPT in potentiating a physiological concentration of glutamate (25 microM)-induced intracellular Ca(2+) rise in these neurons. Further analyses revealed that both PPT and DPN increased ERK phosphorylation, however, the temporal profile and magnitude of response were unique to each molecule. The presence of the L-type Ca(2+) channel inhibitor, nifedipine (10 microM), partially inhibited 17beta-estradiol- and PPT-induced increase in phosphorylated ERK expression, whereas it induced a complete inhibition of DPN-induced increase in ERK phosphorylation. Additional neuroprotective experiments demonstrated that the MAPK inhibitor, PD 98059 (5 microM), partially blocked 17beta-estradiol-induced promotion of neuronal survival against excitotoxic glutamate (200 microM)-induced neurotoxicity, whereas it completely blocked both PPT- and DPN-induced neuroprotection. The presence of the nuclear ER antagonist, ICI 182,780 (1 microM), not only failed to block all 3 molecule-induced neuroprotection, but coadministration of ICI 182,780 and each single molecule exerted a comparable or even greater neuroprotection. Taken together, as an expansion of our previous analyses, these data indicate that both ERalpha and ERbeta contribute to neuronal mechanisms leading to estrogen promotion of neuronal function but with unique signaling profiles. Activation of ERbeta and induction of intracellular Ca(2+) influx via the L-type channels appears to be more closely associated with estrogen promotion of memory mechanisms. However, ERalpha and ERbeta play an equivalently important role in mediating estrogen neuroprotection, and, which is dependent upon the activation of the MAPK signaling. Further, the present analyses suggest that separate from a classical nuclear ER-mediated response, estrogen promotes neuronal survival likely through a non-nuclear cytoplasm or membrane-associated ER-mediated rapid signaling cascade.

Nuclear and Membrane Estrogen Receptor Antagonists Induce Similar Mtorc2 Activation‐reversible Changes in Synaptic Protein Expression and Actin Polymerization in the Mouse Hippocampus

Alterations of the electrophysiological properties from cortical layer 5 pyramidal neurons in temporary rapamycin-treated rodent brain slices.

Estrogen Receptor Β Exerts Neuroprotective Effects by Fine-Tuning Mitochondrial Homeostasis Through NRF1/PGC-1α

Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons

Neuroprotective Effect of Estrogen: Role of Nonsynaptic Nr2b-Containing Nmda Receptors

Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease

Hippocampus-specific Rictor Knockdown Inhibited 17Β-Estradiol Induced Neuronal Plasticity and Spatial Memory Improvement in Ovariectomized Mice.

Mitogen-Activated Protein Kinase Upregulates the Dendritic Translation Machinery in Long-Term Potentiation by Controlling the Mammalian Target of Rapamycin Pathway

Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy

G-Protein-Coupled Receptor 30 Mediates Rapid Neuroprotective Effects of Estrogen Via Depression of NR2B-Containing NMDA Receptors

Genetic removal of eIF2α kinase PERK in mice enables hippocampal L-LTP independent of mTORC1 activity

Dysregulating mTORC1-4E-BP2 signaling in GABAergic interneurons impairs hippocampus-dependent learning and memory

Estrogen Receptors and Type 1 Metabotropic Glutamate Receptors Are Interdependent in Protecting Cortical Neurons against β-Amyloid Toxicity

Estrogen Receptor β Agonist Attenuates Endoplasmic Reticulum Stress-Induced Changes in Social Behavior and Brain Connectivity in Mice

Cerebral Mtor Signal and Pro-Inflammatory Cytokines in Alzheimer's Disease Rats.

A role for BDNF- and NMDAR-induced lysosomal recruitment of mTORC1 in the regulation of neuronal mTORC1 activity

Norepinephrine stabilizes translation-dependent, homosynaptic long-term potentiation through mechanisms requiring the cAMP sensor Epac, mTOR and MAPK

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

Mtor is Essential for Corticosteroid Effects on Hippocampal AMPA Receptor Function and Fear Memory

Tunicamycin Induces Depression-Like Behaviors in Male Rats, Accompanied by Initiated Chaperon-Mediated Autophagy and Decreased Synaptic Protein Expression in the Hippocampus.

ERα stimulation rapidly modulates excitatory synapse properties in female rat nucleus accumbens core